The TGA has provisionally approved Pfizer’s COVID-19 vaccine (COMIRNATY) for administration to children aged 5 to 11 years from 10 January 2022. Vaccinators will need to undertake an additional training module to administer these vaccines.
This follows the provisional approvals granted by the TGA for the use of Pfizer in adolescents 12 years and older, and the booster dose for use in adults 18 years and older.
ATAGI has also updated its recommendations on the use of booster doses of COVID-19 vaccines. Given the likelihood of ongoing transmission of both Omicron and Delta variants, ATAGI now recommends COVID-19 booster vaccination for anyone aged 18 and older who completed their primary course of COVID-19 vaccination four or more months ago. The booster dose interval will be further reduced on 31 January 2022 to three months.
GPs assisting in the management of patients with COVID-19 at home can also access the RACGP’s updated home-care guidelines.
To help doctors navigate the many challenges associated with the vaccination rollout, we have compiled responses to members’ other FAQs on the COVID-19 vaccines to support our general COVID-19 FAQs. These are regularly updated below: